U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions ’ Narcan Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment

GAITHERSBURG, Md., March 29, 2023 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has approved Narcan® Naloxone HCl Nasal Spray 4 mg as an over-the-counter (OTC)...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news